[TITLE]Nuveen LLC Acquires New Holdings in Healthcare Services Group, Inc. $HCSG:
[TEXT]
Nuveen LLC acquired a new stake in Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 1,165,133 shares of the business services provider’s stock, valued at approximately $11,745,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Trail Ridge Investment Advisors LLC lifted its stake in Healthcare Services Group by 4.7% in the 1st quarter. Trail Ridge Investment Advisors LLC now owns 23,233 shares of the business services provider’s stock valued at $234,000 after purchasing an additional 1,048 shares during the last quarter. SummerHaven Investment Management LLC lifted its stake in Healthcare Services Group by 1.8% in the 1st quarter. SummerHaven Investment Management LLC now owns 73,841 shares of the business services provider’s stock valued at $744,000 after purchasing an additional 1,297 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Healthcare Services Group by 3.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,880 shares of the business services provider’s stock valued at $486,000 after acquiring an additional 1,461 shares during the period. North Star Investment Management Corp. increased its position in Healthcare Services Group by 1.8% in the 1st quarter. North Star Investment Management Corp. now owns 102,950 shares of the business services provider’s stock valued at $1,038,000 after acquiring an additional 1,850 shares during the period. Finally, Sterling Capital Management LLC increased its position in Healthcare Services Group by 803.4% in the 4th quarter. Sterling Capital Management LLC now owns 2,358 shares of the business services provider’s stock valued at $27,000 after acquiring an additional 2,097 shares during the period. Institutional investors own 97.97% of the company’s stock.

Get Healthcare Services Group alerts:

Healthcare Services Group Stock Up 3.6%

HCSG opened at $15.77 on Friday. Healthcare Services Group, Inc. has a twelve month low of $9.13 and a twelve month high of $15.80. The company has a fifty day moving average of $14.28 and a 200-day moving average of $12.75. The stock has a market cap of $1.14 billion, a PE ratio of 112.64 and a beta of 0.54.

Analyst Ratings Changes

Healthcare Services Group ( NASDAQ:HCSG Get Free Report ) last posted its quarterly earnings data on Wednesday, July 23rd. The business services provider reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. Healthcare Services Group had a net margin of 0.61% and a return on equity of 11.74%. The company had revenue of $458.50 million during the quarter, compared to analysts’ expectations of $450.78 million. During the same period in the prior year, the company posted $0.20 earnings per share. Healthcare Services Group’s revenue for the quarter was up 7.6% compared to the same quarter last year. Healthcare Services Group has set its Q3 2025 guidance at EPS. Sell-side analysts anticipate that Healthcare Services Group, Inc. will post 0.74 EPS for the current fiscal year.

Several equities analysts have issued reports on the stock. Benchmark upped their price target on shares of Healthcare Services Group from $17.00 to $19.00 and gave the company a “buy” rating in a research report on Thursday, July 24th. Zacks Research upgraded shares of Healthcare Services Group to a “strong-buy” rating in a research report on Tuesday, August 12th. Robert W. Baird upped their price target on shares of Healthcare Services Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, July 24th. Macquarie upgraded shares of Healthcare Services Group from a “neutral” rating to an “outperform” rating and upped their price target for the company from $15.00 to $16.00 in a research report on Tuesday, July 29th. Finally, Wall Street Zen cut shares of Healthcare Services Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $16.25.

View Our Latest Analysis on HCSG

Insider Buying and Selling at Healthcare Services Group

In other news, EVP John Christopher Shea sold 21,368 shares of the stock in a transaction on Monday, July 28th. The shares were sold at an average price of $13.25, for a total transaction of $283,126.00. Following the completion of the sale, the executive vice president directly owned 32,976 shares in the company, valued at $436,932. This represents a 39.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.60% of the stock is currently owned by company insiders.

Healthcare Services Group Company Profile

(Free Report)

Healthcare Services Group, Inc provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary.

Further Reading

Want to see what other hedge funds are holding HCSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report).

Receive News & Ratings for Healthcare Services Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Services Group and related companies with MarketBeat.com's FREE daily email newsletter.
[Source link]: https://www.etfdailynews.com/2025/08/23/nuveen-llc-acquires-new-holdings-in-healthcare-services-group-inc-hcsg/


[TITLE]HighTower Advisors LLC Acquires 48,247 Shares of American Healthcare REIT, Inc. $AHR:
[TEXT]
HighTower Advisors LLC raised its holdings in shares of American Healthcare REIT, Inc. (NYSE:AHR – Free Report) by 68.9% during the first quarter, according to its most recent filing with the SEC. The firm owned 118,230 shares of the company’s stock after purchasing an additional 48,247 shares during the period. HighTower Advisors LLC owned 0.08% of American Healthcare REIT worth $3,582,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of AHR. Invesco Ltd. raised its stake in American Healthcare REIT by 1,543.1% in the first quarter. Invesco Ltd. now owns 5,022,455 shares of the company’s stock worth $152,180,000 after buying an additional 4,716,792 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of American Healthcare REIT by 22.4% in the 1st quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company’s stock valued at $569,494,000 after acquiring an additional 3,437,861 shares during the period. Nuveen LLC bought a new position in shares of American Healthcare REIT in the 1st quarter worth $68,097,000. Northern Trust Corp raised its position in shares of American Healthcare REIT by 99.0% in the 4th quarter. Northern Trust Corp now owns 1,732,882 shares of the company’s stock worth $49,249,000 after acquiring an additional 861,882 shares in the last quarter. Finally, Waterfront Capital Partners LLC purchased a new stake in shares of American Healthcare REIT during the 4th quarter worth $15,066,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

Get American Healthcare REIT alerts:

Insider Buying and Selling at American Healthcare REIT

In other news, CIO Stefan K.L. Oh sold 3,860 shares of the firm’s stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total value of $139,346.00. Following the completion of the transaction, the executive directly owned 95,671 shares in the company, valued at $3,453,723.10. This trade represents a 3.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.92% of the company’s stock.

American Healthcare REIT Stock Up 1.7%

NYSE:AHR opened at $42.4430 on Friday. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41. American Healthcare REIT, Inc. has a twelve month low of $19.53 and a twelve month high of $42.54. The company has a market cap of $7.15 billion, a PE ratio of -192.92, a P/E/G ratio of 2.13 and a beta of 1.08. The company’s 50 day moving average is $37.91 and its two-hundred day moving average is $33.42.

American Healthcare REIT (NYSE:AHR – Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.40 by $0.02. The business had revenue of $542.50 million during the quarter, compared to the consensus estimate of $539.49 million. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The business’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.33 earnings per share. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Analysts anticipate that American Healthcare REIT, Inc. will post 1.41 EPS for the current year.

American Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, June 30th. American Healthcare REIT’s payout ratio is presently -454.55%.

Analyst Ratings Changes

A number of brokerages have commented on AHR. KeyCorp boosted their target price on shares of American Healthcare REIT from $34.00 to $40.00 and gave the stock an “overweight” rating in a report on Wednesday, June 11th. Royal Bank Of Canada boosted their price objective on shares of American Healthcare REIT from $39.00 to $45.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Baird R W raised shares of American Healthcare REIT to a “strong-buy” rating in a research report on Thursday, July 17th. JMP Securities lifted their price target on shares of American Healthcare REIT from $40.00 to $45.00 and gave the stock a “market outperform” rating in a report on Monday, August 11th. Finally, Scotiabank started coverage on American Healthcare REIT in a report on Monday, June 30th. They set a “sector outperform” rating and a $42.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating and ten have given a Buy rating to the company. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $41.11.

Read Our Latest Analysis on American Healthcare REIT

American Healthcare REIT Company Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Further Reading

Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR – Free Report).

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
[Source link]: https://www.etfdailynews.com/2025/08/22/hightower-advisors-llc-acquires-48247-shares-of-american-healthcare-reit-inc-ahr/


[Failed to load article at https://financialpost.com/pmn/business-wire-news-releases-pmn/citiustech-acquires-health-data-movers-enhances-healthcare-provider-offerings-with-epic-implementation-capabilities]


[Failed to load article at https://financialpost.com/pmn/business-wire-news-releases-pmn/sonitor-and-tagnos-announce-strategic-merger-paving-the-way-for-enhanced-healthcare-technology-solutions]

================================================================================

[TITLE]Nuveen LLC Acquires New Holdings in Healthcare Services Group, Inc. $HCSG:
[TEXT]
Nuveen LLC acquired a new stake in Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 1,165,133 shares of the business services provider’s stock, valued at approximately $11,745,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Trail Ridge Investment Advisors LLC lifted its stake in Healthcare Services Group by 4.7% in the 1st quarter. Trail Ridge Investment Advisors LLC now owns 23,233 shares of the business services provider’s stock valued at $234,000 after purchasing an additional 1,048 shares during the last quarter. SummerHaven Investment Management LLC lifted its stake in Healthcare Services Group by 1.8% in the 1st quarter. SummerHaven Investment Management LLC now owns 73,841 shares of the business services provider’s stock valued at $744,000 after purchasing an additional 1,297 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Healthcare Services Group by 3.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,880 shares of the business services provider’s stock valued at $486,000 after acquiring an additional 1,461 shares during the period. North Star Investment Management Corp. increased its position in Healthcare Services Group by 1.8% in the 1st quarter. North Star Investment Management Corp. now owns 102,950 shares of the business services provider’s stock valued at $1,038,000 after acquiring an additional 1,850 shares during the period. Finally, Sterling Capital Management LLC increased its position in Healthcare Services Group by 803.4% in the 4th quarter. Sterling Capital Management LLC now owns 2,358 shares of the business services provider’s stock valued at $27,000 after acquiring an additional 2,097 shares during the period. Institutional investors own 97.97% of the company’s stock.

Get Healthcare Services Group alerts:

Healthcare Services Group Stock Up 3.6%

HCSG opened at $15.77 on Friday. Healthcare Services Group, Inc. has a twelve month low of $9.13 and a twelve month high of $15.80. The company has a fifty day moving average of $14.28 and a 200-day moving average of $12.75. The stock has a market cap of $1.14 billion, a PE ratio of 112.64 and a beta of 0.54.

Analyst Ratings Changes

Healthcare Services Group ( NASDAQ:HCSG Get Free Report ) last posted its quarterly earnings data on Wednesday, July 23rd. The business services provider reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. Healthcare Services Group had a net margin of 0.61% and a return on equity of 11.74%. The company had revenue of $458.50 million during the quarter, compared to analysts’ expectations of $450.78 million. During the same period in the prior year, the company posted $0.20 earnings per share. Healthcare Services Group’s revenue for the quarter was up 7.6% compared to the same quarter last year. Healthcare Services Group has set its Q3 2025 guidance at EPS. Sell-side analysts anticipate that Healthcare Services Group, Inc. will post 0.74 EPS for the current fiscal year.

Several equities analysts have issued reports on the stock. Benchmark upped their price target on shares of Healthcare Services Group from $17.00 to $19.00 and gave the company a “buy” rating in a research report on Thursday, July 24th. Zacks Research upgraded shares of Healthcare Services Group to a “strong-buy” rating in a research report on Tuesday, August 12th. Robert W. Baird upped their price target on shares of Healthcare Services Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, July 24th. Macquarie upgraded shares of Healthcare Services Group from a “neutral” rating to an “outperform” rating and upped their price target for the company from $15.00 to $16.00 in a research report on Tuesday, July 29th. Finally, Wall Street Zen cut shares of Healthcare Services Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $16.25.

View Our Latest Analysis on HCSG

Insider Buying and Selling at Healthcare Services Group

In other news, EVP John Christopher Shea sold 21,368 shares of the stock in a transaction on Monday, July 28th. The shares were sold at an average price of $13.25, for a total transaction of $283,126.00. Following the completion of the sale, the executive vice president directly owned 32,976 shares in the company, valued at $436,932. This represents a 39.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.60% of the stock is currently owned by company insiders.

Healthcare Services Group Company Profile

(Free Report)

Healthcare Services Group, Inc provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary.

Further Reading

Want to see what other hedge funds are holding HCSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report).

Receive News & Ratings for Healthcare Services Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Services Group and related companies with MarketBeat.com's FREE daily email newsletter.
[Source link]: https://www.etfdailynews.com/2025/08/23/nuveen-llc-acquires-new-holdings-in-healthcare-services-group-inc-hcsg/


[TITLE]HighTower Advisors LLC Acquires 48,247 Shares of American Healthcare REIT, Inc. $AHR:
[TEXT]
HighTower Advisors LLC raised its holdings in shares of American Healthcare REIT, Inc. (NYSE:AHR – Free Report) by 68.9% during the first quarter, according to its most recent filing with the SEC. The firm owned 118,230 shares of the company’s stock after purchasing an additional 48,247 shares during the period. HighTower Advisors LLC owned 0.08% of American Healthcare REIT worth $3,582,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of AHR. Invesco Ltd. raised its stake in American Healthcare REIT by 1,543.1% in the first quarter. Invesco Ltd. now owns 5,022,455 shares of the company’s stock worth $152,180,000 after buying an additional 4,716,792 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of American Healthcare REIT by 22.4% in the 1st quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company’s stock valued at $569,494,000 after acquiring an additional 3,437,861 shares during the period. Nuveen LLC bought a new position in shares of American Healthcare REIT in the 1st quarter worth $68,097,000. Northern Trust Corp raised its position in shares of American Healthcare REIT by 99.0% in the 4th quarter. Northern Trust Corp now owns 1,732,882 shares of the company’s stock worth $49,249,000 after acquiring an additional 861,882 shares in the last quarter. Finally, Waterfront Capital Partners LLC purchased a new stake in shares of American Healthcare REIT during the 4th quarter worth $15,066,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

Get American Healthcare REIT alerts:

Insider Buying and Selling at American Healthcare REIT

In other news, CIO Stefan K.L. Oh sold 3,860 shares of the firm’s stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total value of $139,346.00. Following the completion of the transaction, the executive directly owned 95,671 shares in the company, valued at $3,453,723.10. This trade represents a 3.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.92% of the company’s stock.

American Healthcare REIT Stock Up 1.7%

NYSE:AHR opened at $42.4430 on Friday. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41. American Healthcare REIT, Inc. has a twelve month low of $19.53 and a twelve month high of $42.54. The company has a market cap of $7.15 billion, a PE ratio of -192.92, a P/E/G ratio of 2.13 and a beta of 1.08. The company’s 50 day moving average is $37.91 and its two-hundred day moving average is $33.42.

American Healthcare REIT (NYSE:AHR – Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.40 by $0.02. The business had revenue of $542.50 million during the quarter, compared to the consensus estimate of $539.49 million. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The business’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.33 earnings per share. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Analysts anticipate that American Healthcare REIT, Inc. will post 1.41 EPS for the current year.

American Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, June 30th. American Healthcare REIT’s payout ratio is presently -454.55%.

Analyst Ratings Changes

A number of brokerages have commented on AHR. KeyCorp boosted their target price on shares of American Healthcare REIT from $34.00 to $40.00 and gave the stock an “overweight” rating in a report on Wednesday, June 11th. Royal Bank Of Canada boosted their price objective on shares of American Healthcare REIT from $39.00 to $45.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Baird R W raised shares of American Healthcare REIT to a “strong-buy” rating in a research report on Thursday, July 17th. JMP Securities lifted their price target on shares of American Healthcare REIT from $40.00 to $45.00 and gave the stock a “market outperform” rating in a report on Monday, August 11th. Finally, Scotiabank started coverage on American Healthcare REIT in a report on Monday, June 30th. They set a “sector outperform” rating and a $42.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating and ten have given a Buy rating to the company. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $41.11.

Read Our Latest Analysis on American Healthcare REIT

American Healthcare REIT Company Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Further Reading

Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR – Free Report).

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
[Source link]: https://www.etfdailynews.com/2025/08/22/hightower-advisors-llc-acquires-48247-shares-of-american-healthcare-reit-inc-ahr/


[TITLE]Charles Schwab Investment Management Inc. Increases Stock Position in AMN Healthcare Services Inc $AMN:
[TEXT]
Charles Schwab Investment Management Inc. boosted its stake in AMN Healthcare Services Inc (NYSE:AMN – Free Report) by 1.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 904,275 shares of the company’s stock after purchasing an additional 17,064 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in AMN Healthcare Services were worth $22,119,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Janney Montgomery Scott LLC raised its stake in AMN Healthcare Services by 34.4% in the first quarter. Janney Montgomery Scott LLC now owns 15,145 shares of the company’s stock valued at $370,000 after purchasing an additional 3,880 shares in the last quarter. Wealth Enhancement Advisory Services LLC bought a new position in AMN Healthcare Services during the first quarter valued at approximately $592,000. Golden State Wealth Management LLC grew its position in AMN Healthcare Services by 107.0% during the first quarter. Golden State Wealth Management LLC now owns 1,159 shares of the company’s stock valued at $28,000 after acquiring an additional 599 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new position in AMN Healthcare Services during the first quarter valued at approximately $1,581,000. Finally, GAMMA Investing LLC grew its position in AMN Healthcare Services by 74.9% during the first quarter. GAMMA Investing LLC now owns 5,278 shares of the company’s stock valued at $129,000 after acquiring an additional 2,260 shares during the last quarter. 99.23% of the stock is owned by hedge funds and other institutional investors.

Get AMN Healthcare Services alerts:

AMN Healthcare Services Stock Down 3.1%

Shares of AMN Healthcare Services stock opened at $19.6650 on Friday. The company has a debt-to-equity ratio of 1.51, a quick ratio of 1.00 and a current ratio of 1.00. AMN Healthcare Services Inc has a 52-week low of $14.86 and a 52-week high of $54.01. The stock has a market capitalization of $753.56 million, a price-to-earnings ratio of -2.53 and a beta of 0.10. The company’s 50 day moving average price is $20.07 and its 200-day moving average price is $21.65.

Wall Street Analyst Weigh In

AMN Healthcare Services ( NYSE:AMN Get Free Report ) last issued its earnings results on Thursday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.13. AMN Healthcare Services had a negative net margin of 10.75% and a positive return on equity of 11.09%. The firm had revenue of $658.18 million for the quarter, compared to analysts’ expectations of $652.89 million. During the same quarter last year, the business earned $0.98 earnings per share. The business’s revenue was down 11.1% on a year-over-year basis. AMN Healthcare Services has set its Q3 2025 guidance at EPS. Equities research analysts forecast that AMN Healthcare Services Inc will post 1.33 EPS for the current year.

A number of brokerages have commented on AMN. UBS Group reduced their price target on shares of AMN Healthcare Services from $30.00 to $25.50 and set a “neutral” rating on the stock in a research report on Tuesday, May 13th. BMO Capital Markets reduced their price target on shares of AMN Healthcare Services from $27.00 to $22.00 and set an “outperform” rating on the stock in a research report on Monday, August 11th. Finally, JMP Securities reduced their price target on shares of AMN Healthcare Services from $33.00 to $22.00 and set a “market outperform” rating on the stock in a research report on Tuesday, August 12th. Three analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, AMN Healthcare Services currently has an average rating of “Hold” and a consensus price target of $28.25.

Get Our Latest Report on AMN
[Source link]: https://www.etfdailynews.com/2025/08/22/charles-schwab-investment-management-inc-increases-stock-position-in-amn-healthcare-services-inc-amn/


[TITLE]Public Sector Pension Investment Board Has $2.35 Million Stock Position in Healthcare Services Group, Inc. $HCSG:
[TEXT]
Public Sector Pension Investment Board grew its holdings in shares of Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report) by 27.6% in the first quarter, Holdings Channel reports. The institutional investor owned 233,034 shares of the business services provider’s stock after acquiring an additional 50,462 shares during the period. Public Sector Pension Investment Board’s holdings in Healthcare Services Group were worth $2,349,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Sterling Capital Management LLC grew its holdings in shares of Healthcare Services Group by 803.4% during the fourth quarter. Sterling Capital Management LLC now owns 2,358 shares of the business services provider’s stock valued at $27,000 after buying an additional 2,097 shares during the last quarter. US Bancorp DE grew its holdings in shares of Healthcare Services Group by 161.4% during the first quarter. US Bancorp DE now owns 8,097 shares of the business services provider’s stock valued at $82,000 after buying an additional 5,000 shares during the last quarter. Bank of Montreal Can acquired a new position in shares of Healthcare Services Group during the fourth quarter valued at
[Source link]: https://www.etfdailynews.com/2025/08/20/public-sector-pension-investment-board-has-2-35-million-stock-position-in-healthcare-services-group-inc-hcsg/

================================================================================

[TITLE]Invesco Ltd. Has $17.38 Million Stake in Supernus Pharmaceuticals, Inc. $SUPN:
[TEXT]
Invesco Ltd. boosted its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 4.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 530,631 shares of the specialty pharmaceutical company’s stock after buying an additional 22,562 shares during the quarter. Invesco Ltd.’s holdings in Supernus Pharmaceuticals were worth $17,378,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Raiffeisen Bank International AG acquired a new position in Supernus Pharmaceuticals during the fourth quarter worth $25,000. Financial Management Professionals Inc. acquired a new position in Supernus Pharmaceuticals during the first quarter worth $30,000. Versant Capital Management Inc increased its position in Supernus Pharmaceuticals by 6,931.3% during the first quarter. Versant Capital Management Inc now owns 1,125 shares of the specialty pharmaceutical company’s stock worth $37,000 after buying an additional 1,109 shares during the last quarter. GF Fund Management CO. LTD. acquired a new stake in shares of Supernus Pharmaceuticals in the fourth quarter valued at
[Source link]: https://www.etfdailynews.com/2025/08/22/invesco-ltd-has-17-38-million-stake-in-supernus-pharmaceuticals-inc-supn/


[TITLE]Amneal Pharmaceuticals, Inc. $AMRX Stake Lifted by Vanguard Group Inc.:
[TEXT]
Vanguard Group Inc. lifted its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 6.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 15,762,727 shares of the company’s stock after purchasing an additional 920,758 shares during the quarter. Vanguard Group Inc. owned 0.05% of Amneal Pharmaceuticals worth $132,092,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Janney Montgomery Scott LLC grew its stake in shares of Amneal Pharmaceuticals by 26.9% in the first quarter. Janney Montgomery Scott LLC now owns 19,350 shares of the company’s stock worth $162,000 after purchasing an additional 4,100 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Amneal Pharmaceuticals by 53.4% in the first quarter. Allspring Global Investments Holdings LLC now owns 60,567 shares of the company’s stock worth $508,000 after purchasing an additional 21,079 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Amneal Pharmaceuticals by 45.7% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 318,420 shares of the company’s stock worth $2,522,000 after purchasing an additional 99,866 shares in the last quarter. California State Teachers Retirement System grew its stake in shares of Amneal Pharmaceuticals by 10.3% in the fourth quarter. California State Teachers Retirement System now owns 131,713 shares of the company’s stock worth $1,043,000 after purchasing an additional 12,282 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its stake in shares of Amneal Pharmaceuticals by 209.2% in the fourth quarter. BNP Paribas Financial Markets now owns 168,194 shares of the company’s stock worth $1,332,000 after purchasing an additional 113,796 shares in the last quarter. Institutional investors own 31.82% of the company’s stock.

Get Amneal Pharmaceuticals alerts:

Insider Activity

In other news, EVP Andrew S. Boyer sold 33,436 shares of the company’s stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $9.05, for a total transaction of $302,595.80. Following the completion of the sale, the executive vice president directly owned 256,670 shares of the company’s stock, valued at $2,322,863.50. This represents a 11.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Jason B. Daly sold 22,000 shares of the company’s stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $9.05, for a total value of $199,100.00. Following the sale, the executive vice president directly owned 10,606 shares of the company’s stock, valued at approximately $95,984.30. This represents a 67.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 177,130 shares of company stock worth $1,619,733 over the last 90 days. 26.56% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

AMRX has been the subject of several recent analyst reports. The Goldman Sachs Group initiated coverage on Amneal Pharmaceuticals in a research note on Friday, June 6th. They issued a “buy” rating and a $12.00 price target for the company. Wall Street Zen cut Amneal Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, May 13th. Five equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Amneal Pharmaceuticals currently has an average rating of “Buy” and a consensus price target of $11.60.

Read Our Latest Stock Report on AMRX

Amneal Pharmaceuticals Stock Up 1.3%

Shares of Amneal Pharmaceuticals stock opened at $9.53 on Friday. The firm has a market cap of $2.99 billion, a price-to-earnings ratio of 953.95 and a beta of 1.11. The business has a fifty day simple moving average of $8.34 and a 200-day simple moving average of $8.00. Amneal Pharmaceuticals, Inc. has a fifty-two week low of $6.68 and a fifty-two week high of $9.62.

Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.06. Amneal Pharmaceuticals had a negative return on equity of 189.49% and a net margin of 0.12%. Amneal Pharmaceuticals has set its FY 2025 guidance at 0.700-0.750 EPS. Analysts anticipate that Amneal Pharmaceuticals, Inc. will post 0.53 earnings per share for the current fiscal year.
[Source link]: https://www.etfdailynews.com/2025/08/22/amneal-pharmaceuticals-inc-amrx-stake-lifted-by-vanguard-group-inc/


[TITLE]Vanguard Group Inc. Has $170.80 Million Stake in Recursion Pharmaceuticals, Inc. $RXRX:
[TEXT]
Vanguard Group Inc. trimmed its position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 5.1% in the 1st quarter, Holdings Channel reports. The institutional investor owned 32,287,977 shares of the company’s stock after selling 1,722,017 shares during the period. Vanguard Group Inc. owned 0.08% of Recursion Pharmaceuticals worth $170,803,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Brighton Jones LLC increased its holdings in shares of Recursion Pharmaceuticals by 49.4% during the 4th quarter. Brighton Jones LLC now owns 20,261 shares of the company’s stock valued at $137,000 after acquiring an additional 6,699 shares during the last quarter. Wells Fargo & Company MN grew its position in Recursion Pharmaceuticals by 298.5% during the fourth quarter. Wells Fargo & Company MN now owns 458,321 shares of the company’s stock worth $3,098,000 after buying an additional 343,304 shares in the last quarter. Envestnet Asset Management Inc. grew its position in Recursion Pharmaceuticals by 5.3% during the fourth quarter. Envestnet Asset Management Inc. now owns 231,756 shares of the company’s stock worth $1,567,000 after buying an additional 11,646 shares in the last quarter. Invesco Ltd. raised its position in Recursion Pharmaceuticals by 54.6% in the fourth quarter. Invesco Ltd. now owns 178,619 shares of the company’s stock worth $1,207,000 after purchasing an additional 63,068 shares in the last quarter. Finally, Legal & General Group Plc raised its position in Recursion Pharmaceuticals by 26.7% in the fourth quarter. Legal & General Group Plc now owns 253,426 shares of the company’s stock worth $1,713,000 after purchasing an additional 53,458 shares in the last quarter. 89.06% of the stock is currently owned by institutional investors and hedge funds.

Get Recursion Pharmaceuticals alerts:

Insiders Place Their Bets

In related news, insider Najat Khan sold 36,599 shares of the company’s stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $5.52, for a total value of $202,026.48. Following the transaction, the insider owned 668,197 shares in the company, valued at approximately $3,688,447.44. This represents a 5.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 8.43% of the stock is currently owned by company insiders.

Recursion Pharmaceuticals Stock Down 6.3%

RXRX stock opened at $4.77 on Thursday. The company has a debt-to-equity ratio of 0.02, a current ratio of 3.58 and a quick ratio of 3.58. The stock has a market capitalization of $2.07 billion, a P/E ratio of -2.68 and a beta of 0.93. The business has a 50-day moving average of $5.47 and a 200-day moving average of $5.80. Recursion Pharmaceuticals, Inc. has a fifty-two week low of $3.79 and a fifty-two week high of $12.36.

Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.06). The company had revenue of $19.10 million during the quarter, compared to analyst estimates of $15.38 million. Recursion Pharmaceuticals had a negative net margin of 1,004.91% and a negative return on equity of 76.09%. Recursion Pharmaceuticals’s revenue was up 33.3% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.40) EPS. On average, sell-side analysts anticipate that Recursion Pharmaceuticals, Inc. will post -1.57 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

RXRX has been the topic of a number of recent analyst reports. Needham & Company LLC restated a “buy” rating and issued a $8.00 price target on shares of Recursion Pharmaceuticals in a research report on Tuesday, July 8th. Morgan Stanley initiated coverage on shares of Recursion Pharmaceuticals in a research report on Thursday, July 3rd. They set an “equal weight” rating and a $5.00 target price on the stock. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $7.00.

Get Our Latest Report on RXRX
[Source link]: https://www.etfdailynews.com/2025/08/21/vanguard-group-inc-has-170-80-million-stake-in-recursion-pharmaceuticals-inc-rxrx/


[TITLE]PNC Financial Services Group Inc. Acquires 216 Shares of iShares U.S. Pharmaceuticals ETF $IHE:
[TEXT]
PNC Financial Services Group Inc. lifted its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Free Report) by 20.3% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 1,281 shares of the company’s stock after buying an additional 216 shares during the period. PNC Financial Services Group Inc.’s holdings in iShares U.S. Pharmaceuticals ETF were worth $90,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. NBC Securities Inc. bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the 1st quarter valued at
[Source link]: https://www.etfdailynews.com/2025/08/21/pnc-financial-services-group-inc-acquires-216-shares-of-ishares-u-s-pharmaceuticals-etf-ihe/

================================================================================

[TITLE]Theratechnologies receives interim order in acquisition by CB Biotechnology THTX:
[TEXT]
We use cookies to improve user experience, and analyze website traffic.

For these reasons, we may share your site usage data with our analytics partners. By clicking "Accept Cookies" you consent to store on your device all the technologies described in our Cookie Policy.
[Source link]: https://thefly.com/permalinks/entry.php/id4184845/THTX-Theratechnologies-receives-interim-order-in-acquisition-by-CB-Biotechnology


[Failed to load article at https://financialpost.com/globe-newswire/theratechnologies-announces-filing-of-special-meeting-materials-and-receipt-of-interim-order-in-relation-to-its-acquisition-by-cb-biotechnology-an-affiliate-of-future-pak]


[TITLE]Theratechnologies Announces Filing of Special Meeting:
[TEXT]
Shareholders stand to receive a significant and attractive cash premium, as the purchase price of US$3.01, with a contingent value right for potential additional aggregate payments of up to US$1.19 per share, represents a compelling premium of 216% to the closing price on the Nasdaq on April 10, 2025, the date prior to the announcement of Future Pak’s initial non-binding proposal.

Board unanimously recommends shareholders vote “FOR” the Arrangement.

Shareholders are encouraged to review the circular carefully and submit their proxies in advance of the proxy voting deadline of 10:00 a.m. (Eastern time) on September 10, 2025.

Visit www.theratech.com
[Source link]: https://www.globenewswire.com/news-release/2025/08/18/3134927/0/en/Theratechnologies-Announces-Filing-of-Special-Meeting-Materials-and-Receipt-of-Interim-Order-in-Relation-to-its-Acquisition-by-CB-Biotechnology-an-Affiliate-of-Future-Pak.html


[TITLE]Vir Biotechnology, Inc. $VIR Shares Acquired by Public Sector Pension Investment Board:
[TEXT]
Public Sector Pension Investment Board lifted its position in shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 27.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 292,578 shares of the company’s stock after purchasing an additional 63,284 shares during the period. Public Sector Pension Investment Board’s holdings in Vir Biotechnology were worth $1,896,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. State of Tennessee Department of Treasury increased its position in shares of Vir Biotechnology by 3.2% during the fourth quarter. State of Tennessee Department of Treasury now owns 39,268 shares of the company’s stock worth $288,000 after purchasing an additional 1,227 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of Vir Biotechnology by 26.2% during the first quarter. PNC Financial Services Group Inc. now owns 10,459 shares of the company’s stock worth $68,000 after purchasing an additional 2,171 shares in the last quarter. Invesco Ltd. grew its holdings in shares of Vir Biotechnology by 0.6% during the fourth quarter. Invesco Ltd. now owns 398,772 shares of the company’s stock worth $2,927,000 after buying an additional 2,574 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Vir Biotechnology by 9.1% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 38,290 shares of the company’s stock worth $248,000 after buying an additional 3,209 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Vir Biotechnology by 5.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 71,332 shares of the company’s stock worth $524,000 after buying an additional 3,506 shares during the last quarter. Institutional investors and hedge funds own 65.32% of the company’s stock.

Get Vir Biotechnology alerts:

Wall Street Analyst Weigh In

A number of research firms recently issued reports on VIR. Raymond James Financial began coverage on Vir Biotechnology in a report on Friday, July 11th. They set an “outperform” rating on the stock. Needham & Company LLC reissued a “buy” rating and set a $14.00 price target on shares of Vir Biotechnology in a report on Thursday, May 22nd. Seven research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $30.25.

Vir Biotechnology Stock Performance

Shares of VIR opened at $4.36 on Thursday. Vir Biotechnology, Inc. has a twelve month low of $4.16 and a twelve month high of $14.45. The stock’s 50 day moving average is $5.16 and its two-hundred day moving average is $6.14. The firm has a market capitalization of $605.69 million, a PE ratio of -1.09 and a beta of 1.18.

Vir Biotechnology (NASDAQ:VIR – Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.80) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.72) by ($0.08). Vir Biotechnology had a negative net margin of 2,895.94% and a negative return on equity of 50.22%. The business had revenue of $1.21 million during the quarter, compared to analysts’ expectations of $2.38 million. During the same period in the prior year, the firm posted ($1.02) EPS. Vir Biotechnology’s revenue for the quarter was down 60.5% compared to the same quarter last year. On average, sell-side analysts predict that Vir Biotechnology, Inc. will post -3.92 EPS for the current year.

Insider Buying and Selling

In other Vir Biotechnology news, EVP Mark Eisner sold 6,796 shares of Vir Biotechnology stock in a transaction that occurred on Tuesday, July 15th. The stock was sold at an average price of $5.47, for a total value of $37,174.12. Following the sale, the executive vice president owned 108,204 shares of the company’s stock, valued at approximately $591,875.88. The trade was a 5.91% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Vicki L. Sato sold 22,000 shares of the business’s stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $4.99, for a total value of $109,780.00. Following the sale, the director directly owned 1,276,391 shares in the company, valued at $6,369,191.09. This trade represents a 1.69% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 57,582 shares of company stock worth $294,930 in the last ninety days. 16.00% of the stock is owned by corporate insiders.

Vir Biotechnology Company Profile

(Free Report)

Vir Biotechnology, Inc, an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company’s preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV).

Read More

Want to see what other hedge funds are holding VIR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report).

Receive News & Ratings for Vir Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vir Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
[Source link]: https://www.etfdailynews.com/2025/08/21/vir-biotechnology-inc-vir-shares-acquired-by-public-sector-pension-investment-board/

================================================================================

[TITLE]Nuveen LLC Acquires New Holdings in Healthcare Services Group, Inc. $HCSG:
[TEXT]
Nuveen LLC acquired a new stake in Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 1,165,133 shares of the business services provider’s stock, valued at approximately $11,745,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Trail Ridge Investment Advisors LLC lifted its stake in Healthcare Services Group by 4.7% in the 1st quarter. Trail Ridge Investment Advisors LLC now owns 23,233 shares of the business services provider’s stock valued at $234,000 after purchasing an additional 1,048 shares during the last quarter. SummerHaven Investment Management LLC lifted its stake in Healthcare Services Group by 1.8% in the 1st quarter. SummerHaven Investment Management LLC now owns 73,841 shares of the business services provider’s stock valued at $744,000 after purchasing an additional 1,297 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Healthcare Services Group by 3.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,880 shares of the business services provider’s stock valued at $486,000 after acquiring an additional 1,461 shares during the period. North Star Investment Management Corp. increased its position in Healthcare Services Group by 1.8% in the 1st quarter. North Star Investment Management Corp. now owns 102,950 shares of the business services provider’s stock valued at $1,038,000 after acquiring an additional 1,850 shares during the period. Finally, Sterling Capital Management LLC increased its position in Healthcare Services Group by 803.4% in the 4th quarter. Sterling Capital Management LLC now owns 2,358 shares of the business services provider’s stock valued at $27,000 after acquiring an additional 2,097 shares during the period. Institutional investors own 97.97% of the company’s stock.

Get Healthcare Services Group alerts:

Healthcare Services Group Stock Up 3.6%

HCSG opened at $15.77 on Friday. Healthcare Services Group, Inc. has a twelve month low of $9.13 and a twelve month high of $15.80. The company has a fifty day moving average of $14.28 and a 200-day moving average of $12.75. The stock has a market cap of $1.14 billion, a PE ratio of 112.64 and a beta of 0.54.

Analyst Ratings Changes

Healthcare Services Group ( NASDAQ:HCSG Get Free Report ) last posted its quarterly earnings data on Wednesday, July 23rd. The business services provider reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. Healthcare Services Group had a net margin of 0.61% and a return on equity of 11.74%. The company had revenue of $458.50 million during the quarter, compared to analysts’ expectations of $450.78 million. During the same period in the prior year, the company posted $0.20 earnings per share. Healthcare Services Group’s revenue for the quarter was up 7.6% compared to the same quarter last year. Healthcare Services Group has set its Q3 2025 guidance at EPS. Sell-side analysts anticipate that Healthcare Services Group, Inc. will post 0.74 EPS for the current fiscal year.

Several equities analysts have issued reports on the stock. Benchmark upped their price target on shares of Healthcare Services Group from $17.00 to $19.00 and gave the company a “buy” rating in a research report on Thursday, July 24th. Zacks Research upgraded shares of Healthcare Services Group to a “strong-buy” rating in a research report on Tuesday, August 12th. Robert W. Baird upped their price target on shares of Healthcare Services Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, July 24th. Macquarie upgraded shares of Healthcare Services Group from a “neutral” rating to an “outperform” rating and upped their price target for the company from $15.00 to $16.00 in a research report on Tuesday, July 29th. Finally, Wall Street Zen cut shares of Healthcare Services Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $16.25.

View Our Latest Analysis on HCSG

Insider Buying and Selling at Healthcare Services Group

In other news, EVP John Christopher Shea sold 21,368 shares of the stock in a transaction on Monday, July 28th. The shares were sold at an average price of $13.25, for a total transaction of $283,126.00. Following the completion of the sale, the executive vice president directly owned 32,976 shares in the company, valued at $436,932. This represents a 39.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.60% of the stock is currently owned by company insiders.

Healthcare Services Group Company Profile

(Free Report)

Healthcare Services Group, Inc provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary.

Further Reading

Want to see what other hedge funds are holding HCSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report).

Receive News & Ratings for Healthcare Services Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Services Group and related companies with MarketBeat.com's FREE daily email newsletter.
[Source link]: https://www.etfdailynews.com/2025/08/23/nuveen-llc-acquires-new-holdings-in-healthcare-services-group-inc-hcsg/


[TITLE]Charles Schwab Investment Management Inc. Increases Stock Position in AMN Healthcare Services Inc $AMN:
[TEXT]
Charles Schwab Investment Management Inc. boosted its stake in AMN Healthcare Services Inc (NYSE:AMN – Free Report) by 1.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 904,275 shares of the company’s stock after purchasing an additional 17,064 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in AMN Healthcare Services were worth $22,119,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Janney Montgomery Scott LLC raised its stake in AMN Healthcare Services by 34.4% in the first quarter. Janney Montgomery Scott LLC now owns 15,145 shares of the company’s stock valued at $370,000 after purchasing an additional 3,880 shares in the last quarter. Wealth Enhancement Advisory Services LLC bought a new position in AMN Healthcare Services during the first quarter valued at approximately $592,000. Golden State Wealth Management LLC grew its position in AMN Healthcare Services by 107.0% during the first quarter. Golden State Wealth Management LLC now owns 1,159 shares of the company’s stock valued at $28,000 after acquiring an additional 599 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new position in AMN Healthcare Services during the first quarter valued at approximately $1,581,000. Finally, GAMMA Investing LLC grew its position in AMN Healthcare Services by 74.9% during the first quarter. GAMMA Investing LLC now owns 5,278 shares of the company’s stock valued at $129,000 after acquiring an additional 2,260 shares during the last quarter. 99.23% of the stock is owned by hedge funds and other institutional investors.

Get AMN Healthcare Services alerts:

AMN Healthcare Services Stock Down 3.1%

Shares of AMN Healthcare Services stock opened at $19.6650 on Friday. The company has a debt-to-equity ratio of 1.51, a quick ratio of 1.00 and a current ratio of 1.00. AMN Healthcare Services Inc has a 52-week low of $14.86 and a 52-week high of $54.01. The stock has a market capitalization of $753.56 million, a price-to-earnings ratio of -2.53 and a beta of 0.10. The company’s 50 day moving average price is $20.07 and its 200-day moving average price is $21.65.

Wall Street Analyst Weigh In

AMN Healthcare Services ( NYSE:AMN Get Free Report ) last issued its earnings results on Thursday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.13. AMN Healthcare Services had a negative net margin of 10.75% and a positive return on equity of 11.09%. The firm had revenue of $658.18 million for the quarter, compared to analysts’ expectations of $652.89 million. During the same quarter last year, the business earned $0.98 earnings per share. The business’s revenue was down 11.1% on a year-over-year basis. AMN Healthcare Services has set its Q3 2025 guidance at EPS. Equities research analysts forecast that AMN Healthcare Services Inc will post 1.33 EPS for the current year.

A number of brokerages have commented on AMN. UBS Group reduced their price target on shares of AMN Healthcare Services from $30.00 to $25.50 and set a “neutral” rating on the stock in a research report on Tuesday, May 13th. BMO Capital Markets reduced their price target on shares of AMN Healthcare Services from $27.00 to $22.00 and set an “outperform” rating on the stock in a research report on Monday, August 11th. Finally, JMP Securities reduced their price target on shares of AMN Healthcare Services from $33.00 to $22.00 and set a “market outperform” rating on the stock in a research report on Tuesday, August 12th. Three analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, AMN Healthcare Services currently has an average rating of “Hold” and a consensus price target of $28.25.

Get Our Latest Report on AMN
[Source link]: https://www.etfdailynews.com/2025/08/22/charles-schwab-investment-management-inc-increases-stock-position-in-amn-healthcare-services-inc-amn/


[Failed to load article at https://financialpost.com/pmn/business-wire-news-releases-pmn/citiustech-acquires-health-data-movers-enhances-healthcare-provider-offerings-with-epic-implementation-capabilities]


[Failed to load article at https://financialpost.com/pmn/business-wire-news-releases-pmn/sonitor-and-tagnos-announce-strategic-merger-paving-the-way-for-enhanced-healthcare-technology-solutions]

================================================================================

